Clinical Trial

Evaluation of Tonabersat for DME

Study acronym: AN
Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This randomized clinical trial will evaluate the effect of tonabersat compared with placebo on central subfield thickness (CST) in eyes with center-involved diabetic macular edema (CI-DME) and good visual acuity.
Protocol Amendment History 12 amendments
This ClinicalTrials.gov record has been amended 12 times since 2023-02-06; most recent amendment 2025-12-05.
Status change: Recruiting → Active, Not Recruiting 2024-12-16
Status change: Not Yet Recruiting → Recruiting 2023-06-15
Trial Details
NCT Number NCT05727891
Lead Sponsor Jaeb Center for Health Research
Collaborators: National Institutes of Health (NIH), National Eye Institute (NEI), Juvenile Diabetes Research Foundation
Conditions Diabetic Macular Edema
Enrollment 128 participants
Start Date 2023-05-02
Primary Completion 2025-06-27 (estimated)
Study Completion 2026-01 (estimated)
Updated on ClinicalTrials.gov 2025-12-11